Navigation Links
Heraeus to Launch Venus® Bulk Fill Syringes
Date:3/8/2011

SOUTH BEND, Ind., March 8, 2011 /PRNewswire/ -- Heraeus Kulzer, LLC, the leader in advancing dental esthetics and overall dental wellbeing, announced today that as a member of the Venus brand of low stress composites, Venus® Bulk Fill will now be available in syringes this March. The precise syringe delivery of Venus Bulk Fill will provide dentists with an easier, faster restorative solution that is more cost effective per restoration than the traditional incremental layering technique.

(Photo: http://photos.prnewswire.com/prnh/20110308/AQ60957)

Venus® Bulk Fill is used for bulk filling Class I and II restorations in 4mm increments. In an advanced review, REALITY RESEARCH LAB states that Venus Bulk Fill achieved an 85.3% cure goal at the bottom of proximal box (5.2% better than a competitive bulk fill composite) and had significantly lower shrinkage stress than that of conventional flowables.

"The self-adapting handling properties of Venus Bulk Fill provide the ideal flowability into all cavo-surfaces eliminating the chance for voids that can occur with traditional composites and flowables especially at the most critical area when dealing with Class II type restorations -- the gingival box," says Andrew Shannon, DDS.

Venus Bulk Fill Syringe will be available through distributors starting in March. The inherent value of this system is that it was designed with the dentist in mind: "Venus Bulk Fill combines the benefits of time savings and ease of use, but most importantly empowers dentists to provide their patients with a low stress restoration that produces the ultimate in clinical success – a highly esthetic, long lasting restoration," adds Jennifer Kalinowski, Sr. Product Manager for Heraeus.

For more information on Venus Bulk Fill Syringe, please visit www.heraeusdentalusa.com or call (800) 431-1785.

Note to Editors

To learn more about Heraeus Kulzer, please visit www.heraeusdentalusa.com or the global corporate website www.heraeus.com. For product shots, please contact Heraeus Marketing and Communications Department at (800) 431-1785. 

About Heraeus

Heraeus, the precious metals and technology group headquartered in Hanau, Germany, is a global, private company with over 155 years of tradition. Our businesses include dental products and biomaterials, precious metals, sensors, quartz glass, and specialty lighting sources. With product revenues approaching euro 2.6 billion and precious metal trading revenues of euro 13.6 billion, as well as more than 12,300 employees in more than 110 companies worldwide, Heraeus holds a leading position in its global markets.

About Heraeus Dental

The Heraeus Kulzer Dental Division aspires to deliver unparalleled innovation and exceptional products that deliver ultimate value to both dental practitioners and laboratories. While product safety and efficacy are always our main goals, we also aim to create value-based products that unlock new levels of productivity in dental practices and dental laboratories. Interrelated products including the Venus brand of low stress composites, Venus White, Flexitime, Gluma and iBond offer exceptional diagnosis, treatment, and restorative care.

Heraeus also collaborates with health care providers, researchers and academic institutions to support community wellbeing and overall oral health. To that end, Heraeus is a corporate supporter of the National Children's Oral Health Foundation, a nonprofit organization that provides access to care for thousands of underserved children, and the Breast Cancer Research Foundation.


'/>"/>
SOURCE Heraeus Kulzer, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
5. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
6. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
7. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
8. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
9. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
10. Premier Micronutrient Launches Supplement for Hearing Health
11. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... Inc. (NYSE: DPLO ) is pleased to announce the promotion of Paul Urick ... 23, 2016. To learn more about our ... ... ... In his redefined ...
(Date:2/12/2016)... 12, 2016   HeartWare International, Inc . (NASDAQ: ... webcast to discuss its financial results for the three ... February 25, 2016 at 8:00 a.m. ET.  The company ... conference call and webcast.  On the conference call and ... from the fourth quarter and business outlook.   ...
(Date:2/12/2016)... 12, 2016  Sequent Medical, Inc. announced today that ... evaluate the safety and effectiveness of the WEB™ Aneurysm ... intracranial aneurysms.  Prof Laurent Spelle , MD, Head ... Paris, France and Principal Investigator of the ... France and Germany.  Although patients with ruptured ...
Breaking Medicine Technology:
(Date:2/12/2016)... , ... February 12, 2016 , ... The law firm ... and Evangeline Parishes. The purpose of these scholarships is to encourage applicants to ... individuals to seek employment within these two parishes. , “We have available jobs ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... to funding innovative lymphoma research and serving the lymphoma community through a comprehensive ... members of South Florida’s philanthropic community at its 10th anniversary Fashion Luncheon on ...
(Date:2/12/2016)... ... February 12, 2016 , ... Fixed Dose Combination Drug ... p.m. EST, http://www.fdanews.com/fixeddosecombination , Fixed dose combination products ... increased attention from all stakeholders in the development of new chemical entities. , ...
(Date:2/12/2016)... ... , ... As a former television executive, owner Tal Rabinowitz knows how stressful ... decompress, Rabinowitz found herself drawn to a casual meditation class while working at NBC ... implementing a 20-minute-per-day meditation practice with her team. After her tenure at NBC, she ...
(Date:2/12/2016)... ... February 12, 2016 , ... T.E.N., a technology and information ... ISE Southeast Awards 2016. Finalists and winners of the ISE® Awards for both ... and Awards Gala on March 15, 2016 at the Westin Peachtree Plaza, Atlanta. ...
Breaking Medicine News(10 mins):